Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
Notes have priced
Inv. presentation
LIGAND PHARMACEUTICALS INC (LGND) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 0.8% stake in Ligand Pharmaceuticals Incorporated
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A MACQUARIE GROUP LTD reports a 3.7% stake in Ligand Pharmaceuticals Inc.
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2022 SC 13G/A JANUS HENDERSON GROUP PLC reports a 8.6% stake in LIGAND PHARMACEUTICALS INCORPORATED
02/10/2022 SC 13G/A VANGUARD GROUP INC reports a 10.3% stake in Ligand Pharmaceuticals Inc.
02/09/2022 SC 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 8.4% stake in Ligand Pharmaceuticals Incorporated
01/27/2022 SC 13G/A BlackRock Inc. reports a 16.4% stake in LIGAND PHARMACEUTICALS INCORPORATED
01/25/2022 SC 13G/A BlackRock Inc. reports a 16.4% stake in LIGAND PHARMACEUTICALS INCORPORATED
10/12/2021 SC 13G/A VANGUARD GROUP INC reports a 10.3% stake in Ligand Pharmaceuticals Inc.
05/07/2021 SC 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 7.7% stake in Ligand Pharmaceuticals Incorporated
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2021 SC 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 12.7% stake in Ligand Pharmaceuticals Incorporated
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/15/2021 SC 13G/A LIGAND PHARMACEUTICALS INC reports a 4.1% stake in Seelos Therapeutics, Inc.
10/08/2020 SC 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 11.8% stake in Ligand Pharmaceuticals Incorporated
02/13/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2020 SC 13G/A LIGAND PHARMACEUTICALS INC reports a 8.1% stake in Seelos Therapeutics, Inc.
02/12/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2020 SC 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 8.1% stake in Ligand Pharmaceuticals Incorporated
02/10/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2019 SC 13G/A WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 4.6% stake in Ligand Pharmaceuticals Incorporated
02/12/2019 SC 13G/A VANGUARD GROUP INC reports a 9.1% stake in Ligand Pharmaceuticals Inc
02/11/2019 SC 13G/A BlackRock Inc. reports a 13% stake in LIGAND PHARMACEUTICALS INCORPORATED
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018 SC 13G/A KNOTT DAVID M reports a 4.1% stake in Ligand Pharmaceuticals Incorporated
02/09/2018 SC 13G/A VANGUARD GROUP INC reports a 8.8% stake in Ligand Pharmaceuticals Inc
01/19/2018 SC 13G/A BlackRock Inc. reports a 14.2% stake in LIGAND PHARMACEUTICALS INCORPORATED
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy